Bénard J, Da Silva J, De Blois M C, Boyer P, Duvillard P, Chiric E, Riou G
Cancer Res. 1985 Oct;45(10):4970-9.
A cell line, IGROV1, originating from an ovarian carcinoma of a 47-year-old woman was established in tissue culture and in nude mice. Maintained in monolayer cultures, IGROV1 cells exhibited a 20-h doubling time and highly tumorigenic properties. The s.c. injection of 2 X 10(6) cultured cells into nude mice gave rise to fast growing tumors, while the i.p. route induced a peritoneal carcinomatosis with ascites which killed the animals in 2 months. The epithelial morphology of IGROV1 cells was retained during in vitro and in vivo passages, as judged by both the light and the electron microscopes. Two cytogenetic markers characterize IGROV1 cells: a paracentric inversion of chromosome 3, and a translocation between chromosomes 2 and 5. The constitutional karyotype of the patient was normal. These characteristics make the IGROV1 cell line a suitable experimental model for the treatment of human ovarian carcinomas and for biological studies of human solid tumors.
一种源自一名47岁女性卵巢癌的细胞系IGROV1,已通过组织培养和在裸鼠体内建立起来。IGROV1细胞在单层培养中维持时,表现出20小时的倍增时间和高度致瘤特性。将2×10⁶个培养细胞皮下注射到裸鼠体内会产生快速生长的肿瘤,而腹腔注射途径则会诱发伴有腹水的腹膜癌病,在两个月内导致动物死亡。通过光学显微镜和电子显微镜判断,IGROV1细胞的上皮形态在体外和体内传代过程中得以保留。IGROV1细胞有两个细胞遗传学标记:3号染色体的臂内倒位,以及2号和5号染色体之间的易位。该患者的染色体组型正常。这些特性使IGROV1细胞系成为治疗人类卵巢癌和进行人类实体瘤生物学研究的合适实验模型。